Dark

Check out our Dark Pool Levels

REVB
Revelation Biosciences, Inc. Common Stock
stock NASDAQ

At Close

May 12, 2025 3:59:30 PM EDT

3.30USD+3.836%(+0.12)28,194

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 9, 2025 8:03:30 AM EDT

3.07USD-3.401%(-0.11)0

After-hours

May 8, 2025 4:09:30 PM EDT

3.03USD-2.113%(-0.07)0

OverviewHistoricalExchangesShortsNews

Jan 24, 2022

08:06AM EST Revelation Biosciences Raises $7.76M In Equity Financing Benzinga

08:00AM EST Revelation Biosciences Raises $7.76 Million in Equity Financing GlobeNewswire Inc

Jan 20, 2022

09:07AM EST Revelation Biosciences Inc. Announces First Group Of Patients Dosed In Phase 2b Viral Challenge Study To Assess Efficacy Of Intranasal REVTx-99 For The Prevention Of H3N2 Influenza Infection Benzinga

09:00AM EST Revelation Biosciences Inc. Announces First Group of Patients GlobeNewswire Inc

Jan 18, 2022

09:07AM EST Revelation Biosciences Announces First Patient Enrolled, Dosed In Phase 1b Clinical Study Of REVTx-99 For Treatment Of Allergic Rhinitis Benzinga

09:00AM EST Revelation Biosciences Inc. Announces First Patient Enrolled and GlobeNewswire Inc

Jan 13, 2022

01:55PM EST -A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed- GlobeNewswire Inc

Jan 11, 2022

09:05AM EST EXCLUSIVE: Revelation Biosciences Says 'REVTx-99 was tested prior to infection in multiple standard in vitro anti-viral activity assay systems' Benzinga

09:05AM EST EXCLUSIVE: Revelation Biosciences Announces Data Demonstrating REVTx-99 In Vitro Anti-Viral Activity Against SARS-CoV-2 Benzinga

09:05AM EST EXCLUSIVE: Revelation Biosciences Says 'A greater than 50% reduction in SARS-CoV-2 Delta viral was observed' Benzinga

09:00AM EST -A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed- GlobeNewswire Inc

08:55AM EST EXCLUSIVE: New On NASDAQ Deck, Revelation Bio's COVID-19 Antiviral Shows Encouraging Preclinical Action Benzinga

08:55AM EST EXCLUSIVE: Revelation Biosciences Says 'A greater than 50% reduction in SARS-CoV-2 Delta viral was observed' Benzinga

08:55AM EST EXCLUSIVE: Revelation Biosciences Says 'REVTx-99 was tested prior to infection in multiple standard in vitro anti-viral activity assay systems' Benzinga

08:55AM EST EXCLUSIVE: Revelation Biosciences Announces Data Demonstrating REVTx-99 In Vitro Anti-Viral Activity Against SARS-CoV-2 Benzinga

08:01AM EST New On NASDAQ Deck, Revelation Bio's COVID-19 Antiviral Shows Encouraging Preclinical Action Benzinga

Feb 10, 2021

12:48PM EST How Is OTC Markets Different From Exchanges? Benzinga

Share